Spots Global Cancer Trial Database for solumedrol
Every month we try and update this database with for solumedrol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis | NCT02296346 | Secondary Progr... | SoluMedrol Extracorporeal ... | 18 Years - 75 Years | University of Utah | |
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG | NCT00899847 | Transplantation... Transplantation... Multiple Myelom... Blood and Marro... | Autologous peri... Allogeneic peri... Filgrastim Cyclophosphamid... Melphalan Cyclosporine Total lymphoid ... Rabbit anti-thy... Mycophenolate M... Solumedrol Diphenhydramine Acetaminophen Hydrocortisone | 18 Years - 75 Years | Stanford University | |
Allogeneic Transplantation From Related Haploidentical Donors | NCT00185692 | Blood Cancer Leukemia Graft Versus Ho... Malignancy CLL NHL Hodgkin's Disea... MDS | non-myeloablati... Anti-Thymocyte ... Cyclosporine Mycophenolate M... G-CSF Solumedrol Acetaminophen Diphenydramine Hydrocortisone | 12 Months - | Stanford University | |
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | NCT00186628 | Leukemia, Mast-... Mantle-cell Lym... | Total lymphoid ... Rituximab Anti-thymoglobu... Cyclosporine Mycophenylate m... Filgrastim Granisetron Solumedrol Acetaminophen Diphenhydramine Hydrocortisone | 18 Years - 76 Years | Stanford University | |
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis | NCT02296346 | Secondary Progr... | SoluMedrol Extracorporeal ... | 18 Years - 75 Years | University of Utah | |
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia | NCT00968253 | Leukemia Acute Lymphocyt... | Everolimus (RAD... Cyclophosphamid... Vincristine Doxorubicin Dexamethasone Mesna Methotrexate Ara-C (Cytarabi... Methylprednison... G-CSF | 10 Years - | M.D. Anderson Cancer Center | |
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis | NCT02296346 | Secondary Progr... | SoluMedrol Extracorporeal ... | 18 Years - 75 Years | University of Utah |